• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

评估英格兰奥密克戎 COVID-19 加强针后死亡的风险因素。

Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England.

机构信息

Health Analysis and Life Events Division, Office for National Statistics, Newport, United Kingdom.

Department of Mathematics and Statistics, University of Strathclyde, Glasgow, United Kingdom.

出版信息

JAMA Netw Open. 2022 Sep 1;5(9):e2233446. doi: 10.1001/jamanetworkopen.2022.33446.

DOI:10.1001/jamanetworkopen.2022.33446
PMID:36074469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9459656/
Abstract

This cohort study of adults in England evaluates the association of sociodemographic and clinical risk factors with death from COVID-19 among individuals who completed primary vaccination and received a messenger RNA (mRNA) booster.

摘要

这项针对英格兰成年人的队列研究评估了在完成初级疫苗接种并接种信使 RNA（mRNA）加强针的个体中，社会人口学和临床危险因素与 COVID-19 死亡之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d5/9459656/ee9d24baa784/jamanetwopen-e2233446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d5/9459656/ee9d24baa784/jamanetwopen-e2233446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5d5/9459656/ee9d24baa784/jamanetwopen-e2233446-g001.jpg

相似文献

1
Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England.评估英格兰奥密克戎 COVID-19 加强针后死亡的风险因素。
JAMA Netw Open. 2022 Sep 1;5(9):e2233446. doi: 10.1001/jamanetworkopen.2022.33446.
2
Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.自愿降低风险行为可降低 SARS-CoV-2 影响：2022 年 1 月英国奥密克戎疫情实时建模研究。
BMC Med. 2023 Jan 19;21(1):25. doi: 10.1186/s12916-022-02714-5.
3
Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.奥密克戎变异株流行期间英格兰 SARS-CoV-2 感染阳性成年人的新冠相关死亡或住院风险预测（QCOVID4）：队列研究。
BMJ. 2023 Jun 21;381:e072976. doi: 10.1136/bmj-2022-072976.
4
Following the Omicron wave, the majority of children in England have evidence of previous COVID infection.在奥密克戎毒株浪潮之后，英国大多数儿童都有既往新冠病毒感染的迹象。
J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2022.12.012. Epub 2022 Dec 18.
5
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.2020 年至 2022 年期间英格兰与关键人口统计学和临床亚组相关的 COVID-19 死亡率变化：使用 OpenSAFELY 平台的回顾性队列研究。
Lancet Public Health. 2023 May;8(5):e364-e377. doi: 10.1016/S2468-2667(23)00079-8.
6
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月，英国青少年在先前感染和接种疫苗后对 delta（B.1.617.2）和 omicron（B.1.1.529）BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用：一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
7
Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era.在奥密克戎时代模拟英格兰地区 SARS-CoV-2 传播的中期动态。
Nat Commun. 2022 Aug 19;13(1):4879. doi: 10.1038/s41467-022-32404-y.
8
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England.新冠病毒疫苗在英格兰针对奥密克戎（BA.2）变体的有效性
Lancet Infect Dis. 2022 Jul;22(7):931-933. doi: 10.1016/S1473-3099(22)00309-7. Epub 2022 May 24.
9
Modelling and predicting the spatio-temporal spread of COVID-19, associated deaths and impact of key risk factors in England.建立模型并预测英格兰地区 COVID-19 的时空传播、相关死亡人数以及关键风险因素的影响。
Sci Rep. 2021 Mar 8;11(1):5378. doi: 10.1038/s41598-021-83780-2.
10
Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England.与英格兰的BA.2病例相比，SARS-CoV-2奥密克戎BA.4和BA.5病例出现严重后果的风险。
J Infect. 2023 Jul;87(1):e8-e11. doi: 10.1016/j.jinf.2023.04.015. Epub 2023 Apr 24.

引用本文的文献

1
Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England.英格兰接受加强针 COVID-19 疫苗接种的成年人 COVID-19 死亡风险。
Nat Commun. 2024 Jan 16;15(1):398. doi: 10.1038/s41467-023-44276-x.
2
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.2022年秋季新冠病毒加强针接种后出现严重新冠病毒感染后果的风险：一项对涉及英格兰、北爱尔兰、苏格兰和威尔士740万成年人的全国前瞻性队列研究的汇总分析。
Lancet Reg Health Eur. 2023 Dec 12;37:100816. doi: 10.1016/j.lanepe.2023.100816. eCollection 2024 Feb.
3

本文引用的文献

1
Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine rollout: a retrospective, population-based cohort study.疫苗接种阶段英格兰大流行第二波和第三波期间 COVID-19 死亡率的种族差异：一项回顾性、基于人群的队列研究。
BMC Med. 2023 Jan 8;21(1):13. doi: 10.1186/s12916-022-02704-7.
2
Effect of Early Treatment with Ivermectin among Patients with Covid-19.COVID-19 患者早期使用伊维菌素治疗的效果。
N Engl J Med. 2022 May 5;386(18):1721-1731. doi: 10.1056/NEJMoa2115869. Epub 2022 Mar 30.
3
Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.
奥密克戎时代新冠病毒病对免疫功能低下人群的影响：基于观察性人群的INFORM研究的见解
Lancet Reg Health Eur. 2023 Oct 13;35:100747. doi: 10.1016/j.lanepe.2023.100747. eCollection 2023 Dec.
4
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023.临床流行病学和接种与未接种 COVID-19 住院成年人重症结局的危险因素-VISION 网络，10 个州，2021 年 6 月至 2023 年 3 月。
Clin Infect Dis. 2024 Feb 17;78(2):338-348. doi: 10.1093/cid/ciad505.
5
Vaccine-Induced or Hybrid Immunity and COVID-19-Associated Mortality During the Omicron Wave.奥密克戎变异株流行期间疫苗诱导或混合免疫与 COVID-19 相关死亡率。
Dtsch Arztebl Int. 2023 Mar 31;120(13):213-220. doi: 10.3238/arztebl.m2023.0051.
6
Risk Factors Associated with Mortality in Hospitalized Patients with COVID-19 during the Omicron Wave in Brazil.巴西奥密克戎毒株流行期间新冠肺炎住院患者死亡相关危险因素
Bioengineering (Basel). 2022 Oct 20;9(10):584. doi: 10.3390/bioengineering9100584.
7
Error in Table.表格有误。
JAMA Netw Open. 2022 Sep 1;5(9):e2238101. doi: 10.1001/jamanetworkopen.2022.38101.
苏格兰完全接种疫苗人群中与新冠病毒相关死亡的特征及风险
Lancet. 2021 Nov 13;398(10313):1799-1800. doi: 10.1016/S0140-6736(21)02316-3. Epub 2021 Oct 28.
4
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.苏格兰 257 万人中 BNT162b2 和 ChAdOx1 nCoV-19 疫苗接种后 COVID-19 住院和死亡情况（EAVE II）：一项前瞻性队列研究。
Lancet Respir Med. 2021 Dec;9(12):1439-1449. doi: 10.1016/S2213-2600(21)00380-5. Epub 2021 Sep 29.
5
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.新冠病毒疫苗接种后成年人新冠相关死亡和住院的风险预测：全国前瞻性队列研究。
BMJ. 2021 Sep 17;374:n2244. doi: 10.1136/bmj.n2244.
6
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.新冠疫情期间稀缺医疗资源的公平分配
N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23.